Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...

Johnson & Johnson has claimed FDA approval for new formulation of its blockbuster multiple myeloma drug Darzalex that cuts its dosing time to just a few minutes from hours and could help it fend ...

Daratumumab, hyaluronidase-fihj ... Hyaluronidase increases permeability of the subcutaneous tissue by depolymerizing hyaluronan, a polysaccharide found in the extracellular matrix.

DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...

Morningstar brands and products Company Portfolio ...

Jensen-Munroe relapsed in 2023 and was told unfunded, $220,000-a-year drug daratumumab was her “best option”. Unable to afford that, last year she took the second option of a stem cell transplant.

A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous formulations ... with Henlius to make this daratumumab biosimilar available ...

The French river cruise prize package is sold for $29,000 to top bidder Dennis Walsh and Cathie Waites at Rotorua's Supper Club charity fundraiser. The Hits Rotorua 97.5FM presenter Paul Hickey ...

To Pay Chinese player up to $131.6 million for subcutaneous & intravenous formulations ... EU and CN sourced daratumumab. The company is now conducting comparative efficacy studies.